Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Post Info TOPIC: ABBVie & Europe


Guru

Status: Offline
Posts: 1781
Date:
ABBVie & Europe
Permalink  
 


Yes!  let the competition for patients begin.

In the long history of great highly acclaimed first to the market products, its always been good for the first one to have a competitor or a worthy opponent, it really helps to stimulate interest and the market thats out there. There will be more HCV meds coming and they will all be expensive, All these big pharma companies want there piece of the $ pie. But all it will take is one of them to give in and reduce there price uncharacteristically and we could see a tumble in price. Let's hope so, but its unlikely.

matt   



__________________

"And in the end, the love you take is equal to the love you make"

61 year old Geno type A1, F4 Cirrhotic, started 24 weeks on Harvoni 12-17-14 ,EOT-5 week = UND, 8-31-15 =UND , SVR-24 Baby YES! 



Guru

Status: Offline
Posts: 1724
Date:
Permalink  
 

http://www.reuters.com/article/2014/11/21/us-europe-medicine-approvals-idUSKCN0J518920141121

 

(Reuters) - European regulators recommended approval for two drugs made by AbbVie to treat hepatitis C, both of which belong to a new generation of medicines that have proved effective in treating a condition that is the most common cause of liver transplants in Europe.

 

Dasabuvir, known commercially as Exviera, and a combination therapy called Viekirax, gave physicians additional treatment options with high cure rates, the European Medicines Agency said on Friday.



__________________

Diagnosed in 2011, Incivek triple in 2011, tx discontinued, Genotype 1a, CT, VL 7mill, cirrhosis dx in 2012, age 67, waiting for new DAAs.

Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.

Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.